Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ANAC

Arctos NorthStar Acquisition (ANAC) Stock Price, News & Analysis

Arctos NorthStar Acquisition logo

About Arctos NorthStar Acquisition Stock (NASDAQ:ANAC)

Advanced Chart

Key Stats

Today's Range
$10.19
$10.19
50-Day Range
$9.68
$9.79
52-Week Range
$9.44
$10.20
Volume
705 shs
Average Volume
53,611 shs
Market Capitalization
$402.81 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ANAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Arctos NorthStar Acquisition and its competitors with MarketBeat's FREE daily newsletter.

ANAC Stock News Headlines

Northstar Clean Technologies Inc ROOF
Metal Sky Star Acquisition Corp
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Magnificent Seven—seven stocks he believes could deliver similar gains in under six years. His full breakdown is now live.tc pixel
Northstar California Resort
Arctos Northstar Acquisition Corp
See More Headlines

ANAC Stock Analysis - Frequently Asked Questions

Arctos NorthStar Acquisition Corp. (NASDAQ:ANAC) released its quarterly earnings data on Tuesday, May, 10th. The biopharmaceutical company reported ($0.36) earnings per share for the quarter, missing analysts' consensus estimates of ($0.35) by $0.01. Arctos NorthStar Acquisition's revenue for the quarter was up 14.9% compared to the same quarter last year.

Based on aggregate information from My MarketBeat watchlists, some other companies that Arctos NorthStar Acquisition investors own include Portola Pharmaceuticals (PTLA), Micron Technology (MU), Bristol Myers Squibb (BMY), bluebird bio (BLUE), Netflix (NFLX), Palo Alto Networks (PANW) and BioMarin Pharmaceutical (BMRN).

Company Calendar

Last Earnings
5/10/2016
Today
8/19/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
Holding & other investment offices
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:ANAC
CIK
1411158
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$7.16 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-70.78%
Return on Assets
3.97%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.15
Quick Ratio
0.15

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
$0.18 per share
Price / Cash Flow
56.23
Book Value
($0.63) per share
Price / Book
-16.17

Miscellaneous

Outstanding Shares
39,530,000
Free Float
N/A
Market Cap
$402.81 million
Optionable
Not Optionable
Beta
N/A
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:ANAC) was last updated on 8/19/2025 by MarketBeat.com Staff
From Our Partners